Institute for Bioengineering of Catalonia (IBEC)
↗Barcelona, Spain
The Institute for Bioengineering of Catalonia (IBEC) is a leading multidisciplinary research center based in Barcelona, Spain, that focuses on the intersection of engineering and life sciences. Founded in 2005 by the Government of Catalonia, the University of Barcelona (UB), and the Technical University of Catalonia (UPC), IBEC conducts frontier research in nanomedicine, regenerative therapies, and precision medicine. It is a member of the Barcelona Institute of Science and Technology (BIST) and has been recognized as a 'Severo Ochoa Centre of Excellence' multiple times.
IBEC operates as a bridge between basic research and clinical application, maintaining 26 research groups and a staff of over 400 professionals. The institute is highly active in technology transfer, having launched several high-profile spin-offs in the fields of surgical robotics, nanotherapeutics, and diagnostics. Its research programs are structured around three transformative applications: Bioengineering for Future Medicine, Bioengineering for Regenerative Therapies, and Bioengineering for Precision Medicine.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Bioengineering & Nanomedicine Research
SIZE & FINANCIALS
Employees:201-500
Revenue:$10M-$50M
Founded:2005
Ownership:nonprofit
Status:operating
FUNDING
Stage:Not applicable (Research Institute)
Total Raised:€21.5M (Annual Budget 2024)
Investors:Generalitat de Catalunya, Spanish Ministry of Science and Innovation, European Research Council (ERC), la Caixa Foundation
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical (NBT-101 for Bladder Cancer via Nanobots Therapeutics)
Modalities:Nanorobotics, Cell therapy, Gene therapy, Medical Devices, Small molecule (Light-activated), Organ-on-a-chip
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Barcelona Institute of Science and Technology (BIST)
Subsidiaries:Nanobots Therapeutics, Lumiris, Vitala Technologies, Rob Surgical Systems, SurgiTrainer, Eodyne
Key Partnerships:Fraunhofer IBMT (Strategic alliance for Fraunhofer CAT center), Hospital del Mar (Clinical translation agreement), SJD Barcelona Children's Hospital (Translational innovation), University of Barcelona (Academic and research framework), Technical University of Catalonia (UPC) (Robotics and engineering)
COMPETITION
Position:Leader
Competitors:Wyss Institute for Biologically Inspired Engineering, KTH Royal Institute of Technology (Bioengineering), IRB Barcelona, VIB (Flanders Institute for Biotechnology)
LEADERSHIP
Key Executives:
Josep Samitier Martí - Director (until end of 2025)
Manuel Salmerón Sánchez - Interim Director (starting 2026)
Teresa Sanchis - Head of Strategy
Scientific Founders:Josep A. Planell i Estany, Josep Samitier Martí
Board Members:Representatives from Generalitat de Catalunya, Representatives from University of Barcelona (UB), Representatives from Technical University of Catalonia (UPC)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Institute for Bioengineering of Catalonia (IBEC). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.